While fans may be jonesing for a sequel to the 2017 hit movie Call Me By Your Name, one of the stars of the film isn’t so sure the same magic can be recreated.
In a wide-ranging interview with Vulture, Armie Hammer says he’s “coming around to the idea that the first one was so special for everyone who made it, and so many people who watched it felt like it really touched them, or spoke to them.”
Calling the coming-of-age film “a really perfect storm,” Hammer wonders if a sequel is “setting ourselves up for disappointment.”
He added, “I don’t know that anything will match up to the first, you know?”
The talk of a sequel has continued for some time now.
Back in March, director Luca Guadagnino told USA Today the sequel to Call Me By Your Name was being developed with the two stars in mind, but the new film would broaden the setting to a global adventure.
“I’m already conceiving the story with (original novel author) André Aciman, and it’s gonna happen five or six years afterwards,” said Guadagnino.“It’s gonna be a new movie, a different tone.”
Aciman tweeted in December that he’s was in the process of penning a sequel to his original book ahead of a sequel to the critically-acclaimed film.
“I would actually love a sequel to Call Me by Your Name. In fact I am writing one.”
https://twitter.com/aaciman/status/1069745030473109504
In the Vulture interview, though, Hammer makes a point to say he wouldn’t shut the door completely on the idea of returning to the world of CMBYN.
“If we end up with an incredible script, and Timmy’s in, and Luca’s in, I’d be an asshole to say no,” said the 32-year-old actor. “But at the same time, I’m like, That was such a special thing, why don’t we just leave that alone?”
Will young Elio and Oliver ever find true happiness (and peaches) together? We shall see.
On the one hand, I do agree with Armie Hammer about a sequel, but the original novel was so beautifully written, and didn’t exactly follow the traditional plot defined novel, but was more a series of memories, a sequel in the hands of Aciman could work.